- $1.20bn
- $1.39bn
- $796.85m
GoodRx, Novo Nordisk rise on plans to offer Ozempic at $499 per month
Novo Nordisk to offer Ozempic at $499 per month to cash-paying US customers (updated)
GoodRx Holdings Inc reports results for the quarter ended June 30 - Earnings Summary
Brief: GoodRx Holdings Q2 Adjusted Net Income USD 33.9 Million Vs. IBES Estimate USD 37.9 Million
GoodRx Holdings Inc reports results for the quarter ended March 31 - Earnings Summary
GoodRx Holdings Inc reports results for the quarter ended December 31 - Earnings Summary
Brief: GoodRx Holdings Q4 Adjusted Net Income USD 34.7 Million Vs. IBES Estimate USD 37.4 Million
GoodRx Holdings Inc expected to post earnings of 10 cents a share - Earnings Preview
Brief: GoodRx Appoints Christopher Mcginnis As Chief Financial Officer
Brief: Goodrx Appoints Healthcare Industry Veteran, Wendy Barnes, As New Chief Executive Officer
GoodRX appoints Wendy Barnes as CEO; shares rise
U.S. RESEARCH ROUNDUP-Allstate, Mongodb, Primerica
U.S. STOCKS ON THE MOVE-Williams-Sonoma, Inspire Medical
U.S. STOCKS ON THE MOVE-Williams-Sonoma, Inspire Medical, Lemonade Inc
U.S. STOCKS ON THE MOVE-Comcast, Wix.com, Flex
GoodRx Holdings one of the most undervalued stocks, Leerink says
GoodRx Holdings Inc reports results for the quarter ended in September 30 - Earnings Summary
Brief: GoodRx Reports Third Quarter 2024 Results
Brief: GoodRx Holdings Q3 Adjusted Net Income USD 31.9 Million Vs. IBES Estimate USD 33 Million